Green dye to guide early cancer removal
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests whether a special dye (indocyanine green) given through a vein can help doctors see the exact edges and depth of early-stage esophageal or stomach cancer during a minimally invasive procedure to remove it. If you are scheduled for this procedure, the dye may help the surgeon remove the cancer more precisely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a very early stage (superficial) cancer in the esophagus or stomach.
- You are 18 years or older.
- You are scheduled for a procedure called endoscopic submucosal dissection (ESD) at the University Medical Center Groningen.
- You are not allergic to the dye indocyanine green (ICG), iodine, shellfish, or clams.
- You do not have severe kidney disease, severe liver disease, or an overactive thyroid.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special green dye (indocyanine green) injected during minimally invasive stomach cancer surgery helps doctors remove more lymph nodes, which may improve treatment. It is for people with stomach adenocarcinoma that has not spread to distant organs.
This trial tests whether a green dye called indocyanine green can help surgeons find and remove more lymph nodes during laparoscopic surgery for advanced stomach cancer. It may improve the chances of removing all cancer.
This study tests whether using a green dye (called indocyanine green) during keyhole surgery helps doctors find and remove lymph nodes more accurately in stomach cancer. It may help reduce the chance of leaving cancer behind.
This trial tests whether using a green dye (called indocyanine green) during minimally invasive surgery can help the surgeon see and remove lymph nodes more effectively for stomach cancer. The dye is injected near the tumor and may improve the accuracy of lymph node removal, which could help reduce the risk of cancer coming back.
This study tests a dye that helps surgeons see the first lymph nodes during esophageal cancer surgery. It might help remove fewer lymph nodes and reduce side effects.
This trial is testing whether using a special dye (indocyanine green) to check blood flow during esophageal cancer surgery can help prevent leaks at the connection site. It may help make the surgery safer and improve recovery.
Hear when a new Esophageal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.